# Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression

> **NCT00944996** · NA · COMPLETED · sponsor: **Tirat Carmel Mental Health Center** · enrollment: 100 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** SSRI; SNRI; TCA

## Key facts

- **NCT ID:** NCT00944996
- **Lead sponsor:** Tirat Carmel Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2012-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-07-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944996, "Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00944996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*